We recently updated our soy research page with a 2019 dose-response meta-analysis of 23 prospective studies. It included a total of 330,826 participants and found that both soy protein and soy isoflavones had a positive impact on breast cancer mortality (1). A 10 mg/day increase in soy isoflavone intake was associated with a 9% decreased risk of breast cancer mortality, and a 5 g/day increase in soy protein intake was associated with a 12% reduction in breast cancer death (1).
You may also like
Compiled by Ginny Messina, MPH, RD and Reed Mangels, PhD, RD, FADA We have updated Protein Part 2—Research and Weightlifting for Vegans […]
Colorectal cancer is the 4th most commonly diagnosed cancer in the United States and causes the 2nd highest number of cancer-related deaths […]
New meta-analysis finds little to no effect of increasing omega-3s.
Due to growing popularity of collagen supplements and a number of inquiries we’ve received about it, we reviewed the literature on collagen […]